Abstract PS15-06: Results of the Window-of-opportunity PIONEER Trial Evaluating Addition of the Progesterone Receptor (PR) Agonist Megestrol to Letrozole for Early Stage Estrogen Receptor (ER) Positive Breast Cancer: Exploiting ER-PR Interaction